Contact
Please use this form to send email to PR contact of this press release:
Crinetics Pharmaceuticals Receives Orphan Drug Designation for Paltusotine for the Treatment of Acromegaly
TO:
Please use this form to send email to PR contact of this press release:
Crinetics Pharmaceuticals Receives Orphan Drug Designation for Paltusotine for the Treatment of Acromegaly
TO: